Comparison of Hormone Receptor Status in Primary and Recurrent Breast Cancer
Iranian Journal of Cancer Prevention, 04/26/2012
Saedi HS et al. – The current study indicated that receptor status in recurrent tumors did not pose predictable value based on the analysis of hormone receptors in primary stage, so it is not an appropriate basis to set up therapeutic protocol in the metastatic patients. Therefore, tissue sampling and hormone receptor re–analyzing of metastatic sites should be considered in these cases.